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In the post-genomic era, with the se-
quence information of entire genomes
available, we are still far from under-
standing the complexity of the pro-
teome. Proteins orchestrate the complex
and delicate biological processes in
living cells, yet fundamental questions
about protein structure and function
remain open. For example, how are pro-
tein structure and function encoded by
the amino acid sequence and how do
the myriad of post-translational modifi-
cations influence their properties? To dis-
cuss how chemistry can help in expand-
ing our knowledge of protein function, a
group of 80 international scientists gath-
ered in the small town of St. Feliu de
Guixols, on the Costa Brava in Spain. The
occasion was the ESF/EMBO conference
on “Probing the Molecular Basis of Pro-
tein Function through Chemistry”, organ-
ized by Martin Engelhard (MPI Dort-
mund) and Don Hilvert (ETH Z rich).
Technological advances have signifi-
cantly improved our ability to apply syn-
thetic chemistry to large biomolecules,
such as proteins, with the same precision
as previously known for small organic
compounds. This enables the total
chemical synthesis of proteins or the in-
troduction of highly specific perturba-
tions beyond the naturally encoded
structural and chemical repertoire. For
example, amino acids with an unnatural
side chain or backbone composition can
be incorporated to effect one-atom mu-
tations in the protein of interest or to
introduce biophysical probes and post-
translational modifications. The same
chemical tools are explored to build mol-
ecules with tailored activity on the basis
of protein structures.
The introduction of native chemical li-
gation (NCL) made synthetic proteins of
considerable size accessible and has had
a dramatic impact on the field of protein
chemistry. To quote Stephen Kent (Chi-
cago), who introduced this technology:
[1]
“Once you have synthetic access to a
protein, you are only limited by your
imagination”. This was nicely illustrated
by Kent himself with a recent example
from his group,
[2] the 76 amino acid (aa)
ubiquitin, which was assembled from
three peptide fragments by NCL. Having
synthetic access to the protein allowed
the substitution of Gly35, which is found
in the unusual left-handed conformation
that, among the natural L-amino acids,
only glycine can adopt, with an unnatu-
ral D-amino acid (D-Gln). A high-resolu-
tion crystal structure of [D-Gln]-ubiquitin
revealed the predicted left-handed con-
formation of the D-isomer without fur-
ther structural perturbations (Figure 1);
this suggests that nature has indeed se-
lected glycine at this position for its abil-
ity to adopt this conformation.
[2]
One area in which (semi-)synthetic
protein chemistry has proven to be es-
pecially valuable is in the field of post-
translational modifications. Prenylation is
essential for the proper function of
many proteins, for example for the Rab
proteins that are involved in vesicle
transport. However, homogeneous sam-
ples of mono- and double-prenylated
Rab cannot be obtained in significant
yields by overexpression. Roger Goody
(MPI Dortmund) showed how the NCL-
related technique expressed protein liga-
tion (EPL)
[3] was used to join a recombi-
nant version of Rab with a synthetic
peptide that corresponds to the C-termi-
nal sequence of the protein, which in-
cludes the prenylated side chains. Crystal
structures of the prenylated Rab proteins
complexed with RabGDI (GDP-dissocia-
tion inhibitor) provided insights into the
hydrophobic isoprenoid-binding pocket
of RabGDI and suggested a model for
Rab extraction from the membrane by
RabGDI.
[4] That EPL has become an es-
tablished technique was evident from
the number of lectures in which it was
discussed. Christian Becker (MPI Dort-
mund) has used both EPL and protein
trans-splicing mediated by split inteins
for the synthesis of lipid-modified prion
proteins. Carlo Unverzagt (Bayreuth) de-
scribed his progress towards the semi-
synthesis of glycosylated RNase B, and a
new split intein, which can be used to
ligate synthetic probes to recombinant
proteins, was presented by Henning
Mootz (Marburg).
The formation of 4-hydroxyproline is
an important post-translational modifica-
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Figure 1. Crystal structure of [D-Gln35]-ubiquitin.
The figure was created from PDB accession code
1YJ1 (see ref. [2])
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the collagen triple helix. By chemical syn-
thesis of the isoelectric 4-fluoroproline
and its incorporation into synthetic colla-
gen, a hyperstable triple helix was ob-
tained.
[5,6] This earlier report by Ronald
Raines (Wisconsin–Madison) showed that
inductive effects and not hydrogen
bonds of the 4-hydroxyproline are im-
portant for stability. More recent results
that were presented further deciphered
the electronic influence of the stereo-
genic center at the 4-position and sug-
gested how these findings could be ex-
ploited for a controlled self-assembly of
collagen from different strands.
[7]
Proteins can be turned into sensors by
covalently attaching a fluorophore close
to the substrate-binding site. In this fash-
ion, Martin Webb (Imperial College,
London) created phosphate sensors by
linking the environmentally sensitive
fluorophore coumarin to phosphate-
binding proteins.
[8] Sensing the produc-
tion of orthophosphate allowed the
study of ATP-dependent DNA helicases.
In another example, a sensor for the
ADP/ATP ratio was prepared by attach-
ing a coumarin to a nucleoside diphos-
phate kinase.
A very powerful alternative to chemis-
try for the introduction of new functions
in proteins is directed laboratory protein
evolution. Dan Tawfik (Weizman) ad-
dressed the question of the time point
of implementation of new functions in
proteins during evolution. Selected mu-
tations that increased the activity of
PON1 hydrolase and other enzymes to-
wards a promiscuous substrate only
marginally affected the activity of the
mutant proteins for its wild-type sub-
strate. These results support the hypoth-
esis that protein evolution proceeds
through nonspecific intermediates, fol-
lowed by gene duplication to diverge
into robust new functions with subse-
quently acquired mutations.
[9]
Catalytic antibodies have long been
considered promising as useful tailor-
made biocatalysts that can be raised for
a wide range of chemical reactions.
However, their lower catalytic activity
compared to natural enzymes is an in-
herent problem and is, among other rea-
sons, a result of the fact that they are se-
lected for binding to transition state ana-
logues and not for catalysis. Don Hilvert
(ETH Z rich) laid out the structural basis
for the Diels–Alderase activity of a cata-
lytic antibody and showed how, by a
combination of site-directed mutagene-
sis and directed evolution, the substrate
binding and catalytic properties could
be optimized.
[10,11] More on the structure
of evolved proteins was presented by
Sheref Mansy (from the group of J. Szos-
tak, Harvard Medical School), who dis-
cussed the solution structure of an artifi-
cial ATP-binding protein discovered by
using in vitro ribosome display technolo-
gy. In this same session, Robin Leather-
barrow (Imperial College, London) pre-
sented the development of an inhibitor
for the 3C protease from the foot and
mouth disease virus. Victor Bolanos-
Garcia (University of Cambridge) shared
new physical insights into the structural
properties that are important for the
function of BUB1/BUBR1 proteins.
Molecular recognition is of central im-
portance in biological systems. Ernest
Giralt (Barcelona) showed how principles
of protein–protein interactions can be
investigated with synthetic molecules.
Oligomers of chiral, bicyclic guanidines
[12]
interact with peptides and proteins
through shape and charge complemen-
tarity. One such oligomer recognized an
anionic helical patch on the surface of
the tetramerization domain of the
tumor-suppressor protein p53.
[13] Similar
tetraguanidinium compounds also medi-
ate internalization into cells and may
serve as nonhydrolyzable drug carriers.
[14]
Synthetic mimics of discontinuous bind-
ing sites in proteins have been devel-
oped by Jutta Eichler (GBF Braun-
schweig) on cyclic peptide scaffolds and
explored as vaccine candidates. A very
different scaffold for the construction of
protein mimics is made by gold nano-
particles that Rapha l L vy (Liverpool)
covered with peptides with the aim of
introducing biomimetic functions.
Protein–carbohydrate interactions rep-
resent an exquisite example of molecular
recognition between biomolecules. A
main difficulty in the field of carbohy-
drates stems from their complex and
heterogeneous structures. As Peter See-
berger (ETH Z rich) discussed in his lec-
ture, the improved and automated syn-
thesis of oligosaccharides by solid-phase
synthesis
[15] gives rise to fast access of
large amounts of homogeneous sam-
ples. With these synthetic compounds at
hand, biochemical studies can be per-
formed, for example on the glycan-
dependent gp120 protein interactions
during HIV entry.
[16] Importantly, they
also provide a rational approach to the
development of vaccines, as exemplified
in a malaria model with the use of syn-
thetic glycosylphosphatidylinositol, the
toxine of the parasite,
[17] and the synthe-
sis of a tetrasaccharide antigen of Bacil-
lus anthracis.
[18]
When investigating the proteomic
content in a biological sample, such as a
certain tissue, it is crucial to distinguish
between fractions of active and inactive
enzymes. Nicolas Winssinger (Strasbourg)
used a library of small peptide substrates
for proteases that are linked to a fluoro-
phore and a PNA tag. The latter served
as a bar-code for the individual se-
quence of the peptide. Upon incubation
with a mixture of proteases in the
sample, the cleavage of peptides un-
masks the fluorophore. The activity pro-
file can then be spatially deconvoluted
by reading out the fluorescence after hy-
bridization of the PNA tags to a DNA mi-
croarray.
[19] The high sensitivity is a great
advantage of this method, but overlap-
ping activities in the sample could be
problematic. An alternative approach,
presented by Benjamin Cravatt (Scripps
Research Institute), overcomes the latter
limitation and can also be performed in
whole cells and even organisms. Here,
the enzyme’s active site is irreversibly
labeled with a fluorophore, the protein
mixture is separated on an SDS-PAGE
gel, and the marked protein is identified
by MS analysis.
[20] The activity profiles
from various human cancer cell lines can
be clustered into phenotypically relevant
groups to identify interesting proteins
for further analysis.
[21]
Kai Johnsson (EPFL Lausanne) showed
how chemistry in living cells can be used
to study proteins in their “natural” envi-
ronment. Selective chemical labeling
takes place in the cell on the small pro-
teins O
6-alkylguanine DNA alkyl transfer-
ase (AGT)
[22] and acyl-carrier protein
(ACP), which are expressed in a fusion
with the protein of interest. Various
applications are possible, including the
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and the creation of protein microarrays.
Fluorescent labeling can be extended to
time-dependent or orthogonal multicol-
or imaging, as demonstrated by visuali-
zation of the localization of cell-wall
growth in budding yeast.
[23] Cells can
also be “miniaturized”, an approach fol-
lowed by Horst Vogel (EPFL Lausanne).
He described the use of so-called native
vesicles, that is, miniaturized cells con-
taining receptors that are still function-
al.
[24] These native vesicles are used as
single attoliter-sized containers, but also
on microarrays to study electrophysiolo-
gy on a chip. Cell-penetrating peptides
(CPPs) are one possible and relatively
nontoxic way to bring a synthetic and
hydrophilic cargo inside a cell.  lo
Langel (Stockholm) discussed applica-
tions such as delivery of antisense RNA
and plasmids into cells and introduced
an algorithm to predict CPP sequen-
ces.
[25] Tom Muir (Rockefeller University)
discussed aspects of chemical communi-
cation between bacteria, known as
quorum sensing. The bacterial warfare
between staphylococci is mediated by
small peptides known as autoinducing
peptides (AIPs), which contain a unique
thiolactone structure. These peptides
can act as agonists on their own recep-
tor and as antagonist on other Staphylo-
coccus strains and thereby switch viru-
lence on or off.
[26] Chemical synthesis of
AIP variants allowed their structure–func-
tion relationships and the importance of
hydrophobic interactions for binding to
the receptor to be deciphered.
[27]
Chemistry also provides many poten-
tial routes to external control of peptide
and protein secondary structure, for ex-
ample to modulate biological systems in
a defined manner. Luis Moroder (MPI
Martinsried) made the case for light as
the ideal external trigger. Azobenzene is
a well-known photochromic moiety that
can be efficiently switched between the
cis and trans isomers by using light of
different wavelengths.
[28] Incorporation
of the azobenzene moiety into a b-hair-
pin peptide allowed photocontrol over
the conformation of this secondary-
structure element and might be the prel-
ude to regulating the function of entire
proteins in this manner.
[29] Kerstin Rie-
ßelmann (from the group of K. R ck-
Braun, TU Berlin) described a new class
of photoswitchable amino acids based
on hemithioindigo moieties, which could
be used as a photoswitchable element
in cyclic Grb2-SH2 antagonists. Natural
enzymes that undergo photoswitching
are, of course, perfectly adapted to the
light source. Martin Engelhard (MPI Dort-
mund) reported on the conformational
changes within the rhodopsin family of
proteins in response to the signal. These
processes were studied by using site-se-
lectively introduced spin labels. The line
broadening of the EPR signals indicated
the mobility of the protein in this partic-
ular region.
[30] Mudi Sheves (Weizman)
presented the hypothesis that a large
induced dipole is created in the retinal
upon light absorption, which causes
structural rearrangement. To illustrate
this, locked chromophores were synthe-
sized that cannot isomerize, but still
cause movement within the protein.
[31]
Light is not only used for photoswitch-
ing, but is also an important source of
energy. Light-harvesting proteins are cru-
cial to collect this energy. Huub de Groot
(Leiden) used solid-state NMR to study
the direct contacts between light-har-
vesting complexes and the protein
matrix by employing
13C-labeled chloro-
phyll.
[32]
A beautiful account of the application
of physical organic chemistry to biologi-
cal questions regarding a neurotransmit-
ter’s binding to its receptor was given
by Dennis Dougherty (Caltech). Cation–p
interactions are important in the binding
of acetylcholine to the nicotinic acetyl-
choline (nAch) receptor.
[33] Support for
this was obtained by replacement of the
key tryptophan residue involved in bind-
ing by fluorinated analogues, by using
the in vivo nonsense-suppression meth-
odology. In contrast, nicotine was found
to bind in a different fashion, involving
hydrogen bonding to the peptide back-
bone. Introduction of a-hydroxy amino
acids, which give rise to ester linkages in
the backbone, led to reduced hydrogen-
bonding capability and, as a result, re-
duced affinity for nicotine. A long-stand-
ing problem is how ligand binding in
the outer domain is translated into
opening and closing of the channel
inside the membrane. An essential pro-
line residue was identified in the loop
between the membrane helices 2 and 3
of the 5-HT3 receptor that is in contact
with the ligand-binding domain. Ex-
change of this amino acid with various
proline analogues suggested that prolyl
cis–trans isomerization mediates the
signal to open the pore of the channel
(Figure 2).
[34] Hagan Bayley (Oxford)
showed how an a-hemolysin pore is
exploited as an artificial nanoreactor, in
which chemistry can be performed at
the single molecule level. When arsenic
compounds bind to an engineered Cys,
individual bond-forming and -breaking
reactions could be observed. A new de-
velopment that was shown was the
stepwise growth of a single polymer
chain inside this pore.
[35]
Sometimes chaperones are needed to
achieve correct folding of a polypeptide
chain into a functional protein. Cordelia
Schiene-Fischer (MPI Halle) discussed the
DnaK protein, which is a member of the
Hsp70 class of chaperones. It was dem-
onstrated that DnaK facilitates protein
folding by catalyzing the cis–trans iso-
merization of non-prolyl peptide bonds,
which is normally slow on the biological
timescale.
[36] Then the focus shifted to
the early events in protein folding: first
contact and nucleation. Thomas Kiefhab-
er (Biozentrum Basel) used unnatural
amino acids based on xanthone and
naphthalene to study these phenomena.
Upon excitation, rapid triplet–triplet
energy transfer can take place between
the chromophores, provided there is van
der Waals contact.
[37] This could be used
to determine the “speed limit” for pro-
tein folding, and it was found that the
timescale of these initial events is in the
nanosecond range. This methodology
was applied to model peptides and the
protein parvalbumin.
Backbone hydrogen bonding is an im-
portant aspect in protein stability, as is il-
lustrated by the fact that, on average, in
a protein, 1.1 such H-bonds exist per res-
idue. To study them, Jeff Kelly (Scripps
Research Institute) replaced the amide
bond either with an ester group or with
an E alkene, which is isosteric with a
peptide bond. The power of this chemi-
cal approach was demonstrated with a
study of the WW domain from the PIN1
protein, a 34-residue peptide that can be
independently folded.
[38] Replacement of
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drogen bonds crucial for stability with
an ester or E alkene analogue resulted in
unfolded protein. Quantification of the
influence of amide-to-alkene mutation
on the energetics of the transition state
compared to the native state by fM anal-
ysis suggested that loop formation is an
important first step in folding of this
peptide. Finally, this methodology has
been applied to gain more insight into
the structural requirements of amyloid
formation. By incorporation of an E
olefin, in the form of a Phe–Phe isostere
in an amyloid protein, the formation of
spherical aggregates instead of the typi-
cal fibrillar structure was observed;
[39]
this demonstrates the importance of
backbone H-bonding in amyloid struc-
tures.
In summary, chemical approaches can
be extremely powerful for probing the
molecular basis of protein function.
Recent technological advances have
largely expanded the protein space ac-
cessible for the synthetic chemist and
further useful tools are likely to emerge.
Most important for the successful mar-
riage of chemistry and biology, however,
will be the creativity and imagination to
devise the right experiment. It might
have been for this reason, that the con-
ference excursion took the participants
to the museum that is dedicated to, ar-
guably, the most creative and imagina-
tive artist this region has produced: Sal-
vador Dal . But also an exciting scientific
meeting like this one, with stimulating
talks and vivid discussions, certainly
helps and should be followed up in the
future.
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